Evidence map›Paper›PMID 24527395›Full record

ArticleStem cell reports2014

Small-molecule induction promotes corneal epithelial cell differentiation from human induced pluripotent stem cells.

Alexandra Mikhailova, Tanja Ilmarinen, Hannu Uusitalo, Heli Skottman

Abstract read
In one paragraph

Article in Stem cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Focus on seed cells: stem cells in 3D bioprinting of corneal grafts.Frontiers in bioengineering and biotechnology · 2024
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexandra MikhailovaInstitute of Biomedical Technology, University of Tampere, Tampere 33520, Finland ; BioMediTech, Tampere 33520, Finland.
Tanja IlmarinenInstitute of Biomedical Technology, University of Tampere, Tampere 33520, Finland ; BioMediTech, Tampere 33520, Finland.
Hannu UusitaloSILK, Department of Ophthalmology, University of Tampere, Tampere 33520, Finland ; TAUH Eye Center, Tampere University Hospital, Tampere 33520, Finland.
Heli SkottmanInstitute of Biomedical Technology, University of Tampere, Tampere 33520, Finland ; BioMediTech, Tampere 33520, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human induced pluripotent stem cells (hiPSCs) offer unique opportunities for developing novel cell-based therapies and disease modeling. In this study, we developed a directed differentiation method for hiPSCs toward corneal epithelial progenitor cells capable of terminal differentiation toward mature corneal epithelial-like cells. In order to improve the efficiency and reproducibility of our method, we replicated signaling cues active during ocular surface ectoderm development with the help of two small-molecule inhibitors in combination with basic fibroblast growth factor (bFGF) in serum-free and feeder-free conditions. First, small-molecule induction downregulated the expression of pluripotency markers while upregulating several transcription factors essential for normal eye development. Second, protein expression of the corneal epithelial progenitor marker p63 was greatly enhanced, with up to 95% of cells being p63 positive after 5 weeks of differentiation. Third, corneal epithelial-like cells were obtained upon further maturation.

Indexed as

BenzodioxolesCell Culture TechniquesCell DifferentiationCell LineEpithelial CellsEpithelium, CornealEyeFibroblast Growth FactorsHumansImidazolesInduced Pluripotent Stem CellsMembrane ProteinsPyridinesTranscription FactorsTransforming Growth Factor betaWnt Signaling Pathway2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochlorideBenzodioxolesCKAP4 protein, humanFibroblast Growth FactorsImidazolesMembrane ProteinsPyridinesTranscription FactorsTransforming Growth Factor beta

Identifiers

PMID24527395
PMCPMC3923224

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.